SCHEMBL70282

SCHEMBL70282

O=C(Cc1ccccc1F)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.54
ALDH1A1 P00352 3/20 0.54
MAPT P10636 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
KDM4E B2RXH2 2/20 0.50
CYP3A4 P08684 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
CES1 P23141 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
PTPN1 P18031 3/20 0.48
LMNA P02545 2/20 0.47
RAB9A P51151 1/20 0.47
GSK3B P49841 2/20 0.47
TRPA1 O75762 1/20 0.47
HIF1A Q16665 1/20 0.47
VNN1 O95497 1/20 0.46
CXCL8 P10145 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29533518 1.00 MAPK1 (0.54) MAPK1ALDH1A1MAPTTDP1MEN1
SCHEMBL28061321 0.85 ALDH1A1 (0.49) MAPK1ALDH1A1MAPTMEN1KMT2A
SCHEMBL3282677 0.85 ALDH1A1 (0.53) MAPK1ALDH1A1MEN1KMT2ACYP3A4
SCHEMBL6202500 0.85 L3MBTL1 (0.59) MAPK1ALDH1A1MAPTTDP1MEN1
SCHEMBL7265238 0.85 ALDH1A1 (0.49) MAPK1ALDH1A1MAPTTDP1KMT2A
SCHEMBL7196858 0.85 MAPT (0.61) MAPK1ALDH1A1MAPTTDP1MEN1
SCHEMBL966965 0.82 SIGMAR1 (0.46) MAPK1ALDH1A1MAPTTDP1MEN1
SCHEMBL3285925 0.81 PLOD2 (0.57) MAPK1ALDH1A1TDP1HPGDSMN1; SMN2
SCHEMBL3282098 0.81 ALDH1A1 (0.49) MAPK1ALDH1A1TDP1MEN1KMT2A
SCHEMBL29533621 0.81 CXCL8 (0.65) MAPK1ALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220298115-A1 SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) CURADEV PHARMA PVT. LTD. (IN) 2022-09-22 US disclosed
EP-4003961-A2 SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) Curadev Pharma Pvt. Ltd. (IN) 2022-06-01 EP disclosed
CN-114269720-A acetyl-CoA synthetase short chains2(ACSS2) Small molecule inhibitors of 库拉德夫制药私人有限公司 2022-04-01 CN disclosed
WO-2021014415-A2 SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) CURADEV PHARMA PVT. LTD. (IN) 2021-01-28 WO disclosed
WO-2021014415-A2 SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) CURADEV PHARMA PVT. LTD. (IN) 2021-01-28 WO disclosed
US-9656947-B2 Process for creating carbon-carbon bonds using carbonyl compounds CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) 2017-05-23 US disclosed
CN-103420823-B The synthetic method of ��-chloro-4 fluorophenyl benzyl ketones 南京欧信医药技术有限公司 2016-06-08 CN disclosed
US-9283229-B2 Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors NIVALIS THERAPEUTICS, INC. (US) 2016-03-15 US disclosed
US-20150224107-A1 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors N30 PHARMACEUTICALS, LLC 2015-08-13 US disclosed
US-9067893-B2 Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors NIVALIS THERAPEUTICS, INC. (US) 2015-06-30 US disclosed
US-7709507-B2 Therapeutic fluoroethyl ureas ALLERGAN, INC. (US) 2010-05-04 US disclosed
US-20090239810-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-24 US disclosed
WO-2009117676-A2 NOVEL PIPERIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-24 WO disclosed
EP-2018364-A1 THERAPEUTIC FLUOROETHYL UREAS Allergan, Inc. (US) 2009-01-28 EP disclosed
WO-2008123821-A1 4, 5-DIHYDRO-LH-IMIDAZOL-2-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-10-16 WO disclosed
WO-2007137029-A1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN, INC. (US) 2007-11-29 WO disclosed
US-20070270498-A1 THERAPEUTIC FLUOROETHYL UREAS ALLERGAN, INC. 2007-11-22 US disclosed
US-5532374-A Method of preparation of bis-quinolines HITACHI CHEMICAL COMPANY, LTD. (JP) 1996-07-02 US disclosed
US-4393079-A ANTIINFLAMMATORY AROMATIC KETONES BEECHAM GROUP LIMITED (GB) 1983-07-12 US disclosed
US-4216232-A Pharmaceutical compositions BEECHAM GROUP LIMITED (GB) 1980-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150224107-A1 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors QDPR, GSR, CBR1 MAPK1 3801/4885ALDH1A1 207/4885MAPT 3445/4885
US-20090239810-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 MAPK1 4140/4885ALDH1A1 784/4885MAPT 3456/4885
US-20220298115-A1 SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) ACSS2, ACAT1, FADS1 MAPK1 1746/4885ALDH1A1 256/4885MAPT 1049/4885
US-20070270498-A1 THERAPEUTIC FLUOROETHYL UREAS SLC14A1, MAPT, UTS2R MAPK1 1564/4885ALDH1A1 1278/4885MAPT 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.